47
Participants
Start Date
January 22, 2008
Primary Completion Date
January 18, 2012
Study Completion Date
May 16, 2018
dasatinib
Dasatinib is given orally 70 mg BID. Dasatinib will be continued until progression, unacceptable toxicity and up to 2 years (26 cycles, each cycle lasting 4 weeks).
Onkozentrum - Klinik im Park, Zurich
Institut Bergonie, Bordeaux
Centre Paul Strauss, Strasbourg
Hopital Edouard Herriot - Lyon, Lyon
Biomedicum Helsinki, Helsinki
Institut Gustave Roussy, Villejuif
Universitaetsklinikum Essen, Essen
Kantonsspital Baden, Baden
Saint Claraspital AG, Basel
Universitaetsspital-Basel, Basel
Kantonsspital Bruderholz, Bruderholz
Kantonsspital Graubuenden, Chur
Hopital Cantonal Universitaire de Geneve, Geneva
Centre Hospitalier Universitaire Vaudois, Lausanne
Kantonsspital Liestal, Liestal
Kantonsspital - St. Gallen, Sankt Gallen
City Hospital Triemli, Zurich
UniversitaetsSpital Zuerich, Zurich
Swiss Cancer Institute
OTHER